An increase in fat mass is considered to be an important risk factor for the worldwide
increase in type 2 diabetes and cardiovascular disease. However, for a given fat mass, there …

Early in the HIV epidemic, lipodystrophy, characterized by subcutaneous fat loss
(lipoatrophy), with or without central fat accumulation (lipohypertrophy), was recognized as a …

Metabolic complications such as dyslipidemia, insulin resistance, and altered fat distribution
(loss of subcutaneous fat and relatively increased central fat) are common in adults infected …

In patients with pulmonary disease, disease severity and prognosis are determined not only
by lung function impairment (1, 2). In patients with mild, moderate, or severe disease …

In humans, growth hormone (GH) is secreted from the anterior pituitary in a pulsatile pattern.
The traditional view is that this secretory pattern is driven by two counter regulatory …

Lipodystrophy is a medical condition characterized by complete or partial loss of adipose
tissue. Not infrequently, lipodystrophy occurs in combination with pathological accumulation …

Background: It is controversial whether the polycystic ovary syndrome (PCOS) per se
increases low-grade chronic inflammation and whether this relates to central fat excess. In …

Accurate methods for assessing body composition in subjects with obesity and anorexia
nervosa (AN) are important for determination of metabolic and cardiovascular risk factors …

Background There are limited data regarding the clinical, biochemical and liver histological
characteristics of patients with HIV‐associated nonalcoholic fatty liver disease (NAFLD), and …

Background Visceral adipose tissue accumulates during antiretroviral therapy in many
patients who are infected with the human immunodeficiency virus (HIV); this process is …